PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30476649-7	2019	Additionally we have found that (1a, 2b and 3f) compounds had a strong melanogenesis inhibition effect in isobutylmethylxanthine (IBMX)-treated murine melanoma B16F10 cells when tested at low and non cytotoxic dose (10-50 microM), by attenuating the melanin production, intracellular tyrosinase activity and tyrosinase expression.	1-Methyl-3-isobutylxanthine	106-128	tyrosinase	Mus musculus	284-294	
30476649-7	2019	Additionally we have found that (1a, 2b and 3f) compounds had a strong melanogenesis inhibition effect in isobutylmethylxanthine (IBMX)-treated murine melanoma B16F10 cells when tested at low and non cytotoxic dose (10-50 microM), by attenuating the melanin production, intracellular tyrosinase activity and tyrosinase expression.	1-Methyl-3-isobutylxanthine	106-128	tyrosinase	Mus musculus	308-318	
30476649-7	2019	Additionally we have found that (1a, 2b and 3f) compounds had a strong melanogenesis inhibition effect in isobutylmethylxanthine (IBMX)-treated murine melanoma B16F10 cells when tested at low and non cytotoxic dose (10-50 microM), by attenuating the melanin production, intracellular tyrosinase activity and tyrosinase expression.	1-Methyl-3-isobutylxanthine	130-134	tyrosinase	Mus musculus	284-294	
30476649-7	2019	Additionally we have found that (1a, 2b and 3f) compounds had a strong melanogenesis inhibition effect in isobutylmethylxanthine (IBMX)-treated murine melanoma B16F10 cells when tested at low and non cytotoxic dose (10-50 microM), by attenuating the melanin production, intracellular tyrosinase activity and tyrosinase expression.	1-Methyl-3-isobutylxanthine	130-134	tyrosinase	Mus musculus	308-318